ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,159
Screening encounters
2,338
Diagnostic referrals
452
Outstanding pathways
192

Screening pathway

  1. Screening2,338Encounters
  2. Positive finding783Documented findings
  3. Referral452Diagnostic referrals
  4. Follow-up500Diagnostic visits
  5. Outcome260Resolved pathways

Stage totals use different units. Pending pathways: 192. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1209 · EXP-1209Synthetic · Site D

Full participant history through 2026-01-16, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-11-01
  4. · Diagnostic referral · EXP-1209-T-R
  5. · Contact attempt · Unsuccessful
  6. · Barrier documented · Contact difficulty
  7. · Contact attempt · Unsuccessful
  8. · Diagnostic booking · Initial booking
  9. · Barrier documented · Appointment coordination
  10. · Contact attempt · Reached
  11. · Barrier documented · Transport difficulty
  12. · Diagnostic visit · Missed
  13. · Diagnostic booking · Rebooking
  14. · Diagnostic visit · Attended
  15. · Diagnosis · Colposcopy · Biopsy collected
  16. · Diagnosis · Histopathology · No high-grade lesion identified
  17. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-07-26
  18. · Follow-up disposition · Resolved · EXP-1209-T-R
  19. · Screening · HPV DNA · Repeat · Prior VIA positive
  20. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

2159 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2860 · Expanded synthetic participant 2860Site C — Rural Outreach Programme
EXP-2862 · Expanded synthetic participant 2862Site B — Peri-Urban Access Programme
EXP-2865 · Expanded synthetic participant 2865Site B — Peri-Urban Access Programme
EXP-2867 · Expanded synthetic participant 2867Site A — Urban Referral Hub
EXP-2870 · Expanded synthetic participant 2870Site E — Resource-Constrained Navigation Programme
EXP-2871 · Expanded synthetic participant 2871Site D — Community Engagement Programme
EXP-2872 · Expanded synthetic participant 2872Site E — Resource-Constrained Navigation Programme
EXP-2874 · Expanded synthetic participant 2874Site E — Resource-Constrained Navigation Programme
EXP-2876 · Expanded synthetic participant 2876Site B — Peri-Urban Access Programme
EXP-2877 · Expanded synthetic participant 2877Site E — Resource-Constrained Navigation Programme
EXP-2880 · Expanded synthetic participant 2880Site D — Community Engagement Programme
EXP-2881 · Expanded synthetic participant 2881Site E — Resource-Constrained Navigation Programme
EXP-2884 · Expanded synthetic participant 2884Site D — Community Engagement Programme
EXP-2885 · Expanded synthetic participant 2885Site A — Urban Referral Hub
EXP-2886 · Expanded synthetic participant 2886Site C — Rural Outreach Programme
EXP-2887 · Expanded synthetic participant 2887Site B — Peri-Urban Access Programme
EXP-2891 · Expanded synthetic participant 2891Site D — Community Engagement Programme
EXP-2893 · Expanded synthetic participant 2893Site C — Rural Outreach Programme
EXP-2894 · Expanded synthetic participant 2894Site B — Peri-Urban Access Programme
EXP-2895 · Expanded synthetic participant 2895Site A — Urban Referral Hub
EXP-2896 · Expanded synthetic participant 2896Site D — Community Engagement Programme
EXP-2900 · Expanded synthetic participant 2900Site D — Community Engagement Programme
EXP-2902 · Expanded synthetic participant 2902Site A — Urban Referral Hub
EXP-2904 · Expanded synthetic participant 2904Site A — Urban Referral Hub
EXP-2907 · Expanded synthetic participant 2907Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
985
HPV DNA
1007
Cytology
346

Navigation activity

Barrier documented
380
Contact attempt
663
Navigation intervention
158
Diagnostic booking
554
Diagnostic visit
500

Documented barriers

Contact difficulty
118
Transport difficulty
129
Appointment coordination
133

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.